AMLX — Amylyx Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(AMLX)

Amylyx Pharmaceuticals, Inc.

Live chart and latest AMLX stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

AMLX News

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Apr 9, 2026 Yahoo Finance

Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment

Mar 31, 2026 Trefis

Amylyx (AMLX) -7.8%: Earnings Show $0 Revenue, Shelf Filing Adds Dilution Fear

Apr 3, 2026 Quiver Quantitative

Amylyx Pharmaceuticals Stock (AMLX) Opinions on Insider Purchase | AMLX Stock News

Dec 26, 2025 Investing.com

H.C. Wainwright raises Amylyx stock price target to $34 on trial confidence

Mar 5, 2026 Seeking Alpha

Amylyx Pharmaceuticals: Back From The Dead (NASDAQ:AMLX)

Jan 27, 2026 Stock Titan

AMLX SEC Filings - Amylyx Pharmaceuticals 10-K, 10-Q, 8-K Forms

Apr 10, 2026 Sahm

The Bull Case For Amylyx Pharmaceuticals (AMLX) Could Change Following LUCIDITY Trial Enrollment Milestone Completion

Apr 2, 2026 Yahoo Finance

A Look At Amylyx Pharmaceuticals (AMLX) Valuation After Reduced Losses And Late Stage Pipeline Progress

Mar 4, 2026 Stock Titan

Amylyx investors can watch its Needham conference talk live April 15

Apr 8, 2026 Yahoo Finance

Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases

Jan 10, 2026 Stock Titan

Vanguard realigns holdings; AMLX ownership reported at 0% (Vanguard)

Mar 26, 2026 Stock Titan

Long-acting GLP-1 antagonist named for rare post-bariatric hypoglycemia

Jan 8, 2026 Stock Titan

Amylyx (NASDAQ: AMLX) details avexitide Phase 3 timing and cash runway into 2028

Mar 24, 2026 Stock Titan

78-patient trial for post-surgery hypoglycemia heads to Q3 data